WireMinute
Health17 November 2026

China Sacks Gene-Editing Scientist After Six-Year-Old Dies in Trial

China has sacked the scientist who led an experimental gene-editing trial in which a six-year-old girl died, after an official investigation found his team ignored safety warnings and hid the death from the journal that published their research.

China Sacks Gene-Editing Scientist After Six-Year-Old Dies in Trial

Shanghai's municipal government said its investigation found Qiu Zilong was the person mainly responsible for the research. The neuroscientist has been dismissed as deputy director of the Songjiang Research Institute, part of the Shanghai Jiao Tong University School of Medicine, and barred for five years from state science projects and awards. A second researcher, Kan Yang, was dismissed as well, and both men have been entered in a national database of serious research-integrity violations.

The case centres on a six-year-old girl with Snijders Blok-Campeau syndrome, a rare disorder of brain development for which there is no effective treatment. In March 2025 she became the first person in the world to receive a gene-editing therapy aimed at the brain, when doctors at Xinhua Hospital in Shanghai injected a base-editing tool, carried by a virus, into the fluid around her spine. She died a week later, on March 31, of thrombotic microangiopathy, a complication of the gene therapy, the hospital's ethics committee found, and the study was stopped.

Investigators found that the team had received results from a monkey safety study in February 2025 showing liver damage, but did not pass them promptly to the doctor leading the clinical study. The hospital's ethics committee had approved the trial in January 2025 even though the safety evidence was incomplete, and the research paper published in the journal Nature in February 2026 made no mention of the girl or her death. The girl's parents had paid more than $800,000 towards developing the therapy and were not adequately warned of the risk of death, an earlier investigation by the journal Science found. Investigators also found that members of the team took money and gifts from the girl's family without disclosing the conflict.

The clinical leader of the study was removed as head of research at Xinhua Hospital and demoted, and the university and the hospital have been reprimanded and told to review their practices. China has since tightened the rules for the fast-track trials under which the treatment was given, limiting them to top hospitals. The girl's parents and other scientists have asked the journal Nature to withdraw the paper.

Key points

Read on WireMinute

Photo: Yuqi632, CC BY-SA 4.0, via Wikimedia Commons

WireMinute - News, updated every minute. More headlines